Neuroleptic malignant syndrome (NMS) is a rare reaction to antipsychotic drugs that are used to treat schizophrenia, bipolar disorder, and other mental health conditions. It affects the nervous system ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
NMS Capital has appointed Duffy to its operating executive council. In this role, Duffy will work to identify, partner with, and build industry leading businesses within the outsourced pharmaceutical ...
New York, New York--(Newsfile Corp. - October 21, 2022) - DirectMed Parts & Service ("DirectMed"), a medical imaging parts, systems, and service company, and portfolio company NMS Capital ("NMS"), ...
NEW YORK and STRASBOURG, France, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded ...
HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, one of the nation’s leading forensic science and bioanalytical toxicology laboratories, announced today that Dan T. Monahan is the now President and Chief ...
HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, a leader in providing clinical and forensic laboratory services, will announce expansion plans at a ceremony in Horsham today. Hosting local leaders in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results